BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis

Area of Science:

• Rheumatology
• Immunology
• Biochemistry

Background:

• Systemic sclerosis (SSc) is a fibrotic autoimmune disease affecting skin and organs.
• Cutaneous calcinosis affects 20-40% of SSc patients, causing pain and functional limitations.
• Pathomechanisms and predictive markers for SSc-related calcinosis are poorly understood.

Purpose of the Study:

• To compare clinical and laboratory parameters in SSc patients with and without calcinosis.
• To evaluate pro- and anti-calcifying circulating markers and serum calcification potential (T50).
• To characterize the mineral composition of calcinosis deposits.

Main Methods:

• Observational study of 51 female SSc patients (25 with calcinosis, 26 without).
• Comparison of clinical manifestations, autoantibodies (ACA, Scl70), and serum markers.
• Analysis of serum calcification potential (T50) and calcinosis mineral composition.

Main Results:

• Significant differences in clinical features and autoantibodies (ACA, Scl70) between SSc patients with and without calcinosis.
• Elevated serum BMP-4 and potential prognostic role of fetuin A in SSc patients with calcinosis.
• Negative correlation between T50 and clinical severity, suggesting predictive value of calcification markers. Calcinosis samples showed mixed phosphate and carbonate minerals.

Conclusions:

• Distinct clinical and serological profiles are associated with calcinosis in SSc.
• Circulating markers like BMP-4 and fetuin A may play a role in SSc calcinosis pathogenesis and prediction.
• Further research on these markers in larger cohorts is warranted to clarify their role in SSc-related cutaneous calcinosis.